Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Breakthrough designation is pivotal
View:
Post by ScienceFirst on Apr 22, 2022 2:10pm

Breakthrough designation is pivotal

It's the final destination that counts Gorf79.  In the meantime, this is an opportunity to add more if this final destination is FDA approval.  Like it or not.  And that's exactly what the market is showing.  It's not the bullet points in a press release.  It's where the data points.  So far, we need a bit more.  5 new patients was not enough.

So if you're long, than the final destination should be what matters.  Your whining since April 5th is disturbing, annoying as it changes nothing on the data.

Comment by Gorf79 on Apr 22, 2022 3:31pm
Bencro, you were never much of wordsmith but you are suddenly stumbling over your thoughts,  take a breath. No one is going to sue you. Calm down. I am am sure others would also like to know, since we all bought too early, when would you suggest is a good time to buy? Should I be waiting for FDA approval as an entry point or is that “too early” You are clearly a self described “ science ...more  
Comment by ScienceFirst on Apr 22, 2022 3:53pm
You're still at It Gorf79? What is a share price Gorf79 with no clear data?  Ever thought that some might have said "only 5 patients and no clear enough of a trend so I'm out of here as it will take forever and TLT will need money one day?"   I told you 3 times.  Can't you read?  Place a buy order @5$.  
Comment by Gorf79 on Apr 22, 2022 4:11pm
Bencro, “what is a share price”? Well without getting into the fundamentals and principles of the duties and fiduciary responsibilities of public companies in Canada, it represents the value of the company in its simplest terms. Following along these simple lines it is the responsibility of managers of a public company to maximize the financial value of a company to the benefit of shareholders ...more  
Comment by Oilminerdeluxe on Apr 22, 2022 4:18pm
FFS Gorf. Give it a rest and don't act like a child. What is wrong with you? You don't think TLT's management want share price to rise? Well, then you have to ask the same question to EVERY company's management out there that is at 30 cents or have lost share value when a PR was met well. Wait 6 months for more patients to arrive with results. Or is that too long for you?  Be ...more  
Comment by Gorf79 on Apr 22, 2022 4:36pm
I get it that it’s annoying Oilminer. But so is having sh....t shoveled down your throat for years on end. I was never in the “should we sell at $80.00 or hold out for $100.00.” Club that was quite active a month ago. I just want them to actually invest some effort in to a fair valuation. From my perspective that has not happened. Effort has certainly been put into creating dilutive financings ...more  
Comment by Rumpl3StiltSkin on Apr 22, 2022 5:10pm
Gorf, If you are truly just a disgruntled shareholder that decided to sign up to SH finally so you could blow off some steam great, have at it, but be careful, liable laws are pretty strict in Canada, maybe you're not up there, eh? Anyway, IF great news comes out, crushes any shorts, gets SP heading back up towards that $1.20 CAD target, you'll be on the board givin' us all high 5s ...more  
Comment by fredgoodwinson on Apr 22, 2022 5:42pm
Well Gorf you seem to be pressing a lot of buttons here - it`s as if you are expressing some damnable heresy!
Comment by Gorf79 on Apr 22, 2022 6:04pm
Well Fred, you comrades here seem to be of the belief that we are guided by Soviet libel laws. They look at criticism of management as illegal and heresy. Certainly this board is lacking in management level experience and risk taking. Posters are petrified to engage in anything but pro Kremlin discourse for fear of a lawsuit...... LOFNL Our free speech laws are quite expansive. I haven’t said ...more  
Comment by fredgoodwinson on Apr 22, 2022 6:18pm
Must admit to being more taken aback by some of the responses than anything you`ve actually said but just to be sure have a mallet,stake garlic and religious iconography standing by for your next effort. Likewise wishing you a good weekend and indeed to all posters here.
Comment by Johnandrose22 on Apr 22, 2022 9:40pm
Agreed, Fred....this recent discussion board volley is intriguing, if not disturbing, on both sides of the aisle
Comment by fredgoodwinson on Apr 23, 2022 1:05pm
Yes John - there appears to be an intolerance of even the slightest dissent on what is supposed to be a Discussion Board. Perhaps Gorf - like me - belongs to a past in which the Management of Joint Stock Companies reported to their Shareholders in a timely, transparent and meaningful way? It is not as if this doesn’t matter to the health and fortunes of a Company - it absolutely does.  
Comment by patience69 on Apr 23, 2022 1:24pm
Could not agree more Fred. It is really nice to see all of those potential buyout deals. Or in the case of covid all of those potential vaccine or licensing deals. The fact is that all of these mean squat. Lets face it at this point we do not know where our 1433 lies in the covid study. Is it in animal studies?  Is it progressing well or is it in the bottom drawer of someones desk waiting for ...more  
Comment by Rumpl3StiltSkin on Apr 23, 2022 6:24pm
From just a few Months back: “Based on this encouraging data,” stated Arkady Mandel, Theralase’s Interim CEO, “the company intends to move forward in the research, development and commercialization of the Theralase COVID-19 vaccine.” Log 3 99.99% kill rate in vitro, so yes, animal study is next.
Comment by ScienceFirst on Apr 22, 2022 6:46pm
No Gorf79 ...  You still don't get it. It's not about differences in opinion, Soviet Union, etc ....  It's about your silly arguments and hidden agenda.  Data will take care of the valuation.  So far, we're missing some.  Bullet points in press releases, IR, cheerleading, etc ... won't make it.  Neither your whining. The share price increased in ...more  
Comment by ScienceFirst on Apr 22, 2022 4:18pm
Gorf79 ... Still stucked on the share price? Lolll
Comment by ScienceFirst on Apr 22, 2022 4:24pm
"Gorf79 the clown" forgets to take into consideration that Roger has 7.5M reasons to make this work.  And that on top of that, it's the pride to make it to FDA approval that is even more rewarding in terms of pride, after all 12 years. Nooe.  "Gorf79 the clown" Is not even able to simplify his thinking!  And he brags himself as being a smart guy!!!
Comment by gebremeskel on Apr 22, 2022 4:46pm
You certainly are a d!ckhead aren't you Gorf? You know what a d!ckhead is don't you Gorf? According to Merriam-Webster a d!ckhead is "a stupid, contemptible, or annoying man." While you are not stupid in the obvious way, Gorf, I don't believe there would be much dispute on this board that you are contemptible and annoying, and if a man, then, definitively a d!ckhead. Longs ...more  
Comment by ScienceFirst on Apr 22, 2022 4:48pm
Wow!  Nice theory on what is a share price.  By chance you are here!   So all stocks are all fairly valued, no matter what, right?  You never see share price pop-up, especially in the biotech sector, right?  Never, right?   Gees! Ever heard about: - shorts - sell on the news (even when this is real good news) - day traders - time till a pivotal event ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250